Basics |
Inogen, Inc
Inogen Inc is a medical technology company that develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
|
IPO Date: |
February 14, 2014 |
Sector: |
Healthcare |
Industry: |
Medical Devices |
Market Cap: |
$171M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.97 | 2.09%
|
Avg Daily Range (30 D): |
$0.14 | 2.13%
|
Avg Daily Range (90 D): |
$0.24 | 2.82%
|
Institutional Daily Volume |
Avg Daily Volume: |
.23M |
Avg Daily Volume (30 D): |
.22M |
Avg Daily Volume (90 D): |
.28M |
Trade Size |
Avg Trade Size (Sh.): |
71 |
Avg Trade Size (Sh.) (30 D): |
71 |
Avg Trade Size (Sh.) (90 D): |
69 |
Institutional Trades |
Total Inst.Trades: |
2,040 |
Avg Inst. Trade: |
$2.33M |
Avg Inst. Trade (30 D): |
$1.03M |
Avg Inst. Trade (90 D): |
$.82M |
Avg Inst. Trade Volume: |
.04M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.47M |
Avg Closing Trade (30 D): |
$.54M |
Avg Closing Trade (90 D): |
$.54M |
Avg Closing Volume: |
40.56K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q3 2024 |
Basic EPS
|
|
$-.25
|
$-.25
|
Diluted EPS
|
|
$-.25
|
$-.25
|
Revenue
|
$
|
$ 82.28M
|
$ 88.83M
|
Gross Profit
|
$
|
$ 36.37M
|
$ 41.34M
|
Net Income / Loss
|
$
|
$ -6.17M
|
$ -5.96M
|
Operating Income / Loss
|
$
|
$ -7.66M
|
$ -7.79M
|
Cost of Revenue
|
$
|
$ 45.91M
|
$ 47.49M
|
Net Cash Flow
|
$
|
$ 5.12M
|
$ 7.74M
|
PE Ratio
|
|
|
|
|
|
|